ADAR1 Capital Management LLC Has $2.47 Million Stock Position in Bright Minds Biosciences Inc. $DRUGMarket Beat·1 day ago, 02:04 AMDRUG+5.02%
We're Not Very Worried About Bright Minds Biosciences' (CSE:DRUG) Cash Burn RateSimplywall·Jun 30 at 06:55 AMDRUG+5.02%
H.C. Wainwright Keeps Their Buy Rating on Bright Minds Biosciences (DRUG)Tip Ranks·Jun 25 at 03:45 PMDRUG+5.02%
Bright Minds Biosciences to Present at Jefferies Global Healthcare Conference | DRUG Stock NewsStockTitan·May 26 at 10:20 AMDRUG+5.02%BBH-0.30%
Why a $5 Million New Position Signals Confidence in This Epilepsy Drug Pipelinenasdaq·May 21 at 05:00 PMDRUG+5.02%FBT+0.87%
Psychedelic drug stocks are surging after Trump's order to fast-track development for medical usebusinessinsider·Apr 20 at 01:02 PMCMPS+6.15%SILO-1.16%
Bright Minds Biosciences (NASDAQ:DRUG) Earns Buy Rating from BTIG ResearchMarket Beat·Mar 30 at 07:08 AMVHT-1.34%LABU+7.13%
Canadian Securities Exchange Reports January 2026 Performance FiguresNewsfile Corp.·Feb 17 at 09:09 AMDRUG+5.02%
De-Risked Neurology Pipeline and Pivotal 2026 Catalysts Underpin Buy Rating on BMB-101 FranchiseTip Ranks·Feb 13 at 09:45 AMIBB+0.76%DRUG+5.02%
Short Interest in Bright Minds Biosciences Inc. (NASDAQ:DRUG) Rises By 67.5%Market Beat·Jan 31 at 02:55 PMXLV-1.64%PBE-3.00%
Bright Minds Biosciences Inc. (NASDAQ:DRUG) Receives Consensus Recommendation of "Moderate Buy" from AnalystsMarket Beat·Jan 12 at 12:49 AMDRUG+5.02%
Bright Minds Biosciences (NASDAQ:DRUG) Cut to "Sell" at Wall Street ZenMarket Beat·Jan 10 at 12:18 AMDRUG+5.02%
